Skip to main content

NATIXIS ADVISORS, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1018331 Boston, MA

Position in VRTX

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$247,393,876
+$8,081,454 QoQ
Shares Held
554,024
+5.0% QoQ
Ownership
0.218%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 62.409931699709766.ToString("F0")% Shared 0.ToString("F0")% None 37.59006830029024.ToString("F0")%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

NATIXIS ADVISORS, LLC holds $475,548,112 across 32 Biotechnology names. VRTX ranks #1 (52.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
This page
554,024 $247,393,876

All Filings in VRTX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $247,393,876 554,024
2025-12-31 $239,312,422 527,864
2025-09-30 $210,386,657 537,194
2025-06-30 $240,643,955 540,530
2025-03-31 $291,467,481 601,187
2024-12-31 $224,563,238 557,644
2024-09-30 $214,813,940 461,886
2024-06-30 $204,636,120 436,585
2024-03-31 $138,805,653 332,063
2023-12-31 $129,991,589 319,476
2023-09-30 $111,002,084 319,210
2023-06-30 $166,526,626 473,208
2023-03-31 $145,873,628 462,988
2022-12-31 $134,956,133 467,332
2022-09-30 $147,207,925 508,420
2022-06-30 $170,256,108 604,195
2022-03-31 $174,985,081 670,518
2021-12-31 $146,649,318 667,802
2021-09-30 $111,864,663 616,708
2021-06-30 $42,094,496 208,771
2021-03-31 $36,768,968 171,106
2020-12-31 $33,198,207 140,468
2020-09-30 $57,156,629 210,042
2020-06-30 $57,178,586 196,957
2020-03-31 $37,174,214 156,227